Summary.-Antisera to extracts of a variety of bronchogenic carcinoma were raised in rabbits and extensively absorbed with immunoadsorbents prepared with normal lung extracts cyanogen bromide linked to Sepharose 4B, and glutaraldehyde insolubilized normal lung extracts. The antisera were tested by immunodiffusion against a panel of extracts from a variety of bronchogenic carcinoma, foetal lung extracts and pools of normal lung extracts. The results indicate that two distinct antigenic components are associated with bronchogenic carcinoma; one which is present in a high percentage of the tumour extracts tested and appears to have partial identity with a foetal lung component, and one (or more) which is not foetal and appears to have higher cross-reactivity (but not exclusively) with tumours of the same pathological type. Attempts to detect either antibody or antigens relating to these components in the serum of patients with bronchogenic carcinoma by these techniques were unsuccessful. The foetal cross-reacting component was neither carcinoembryonic antigen nor cxl-foetoprotein.
THERE HAVE BEEN a number of reports indicating that extracts from a variety of lung carcinomata contain antigenic components not demonstrable in equivalent extracts of normal human lung. Yachi and his co-workers (Yachi et al., 1968) found that an ammonium sulphate (5000 saturated) cut of tumour extracts contained 2 distinct antigenic components, one of which cross-reacted with a foetal antigen and one which appeared to be specific for tumour extracts. Neither antigenic component was demonstrable in all extracts tested. More recently, Mohr et al. (1974) , using supernatants from tissue cultures of alveolar cell carcinoma as their antigenic preparation and absorbed sheep antiserum, demonstrated a common tumour specific antigen by immunodiffusion with the heterologous antiserum and cell culture supernatants as well as with serum from patients with alveolar cell carcinoma and, in some instances, with Hodgkin's disease. Sega et al. (1974) have reported the presence of tumour specific antigenic material present in a pooled extract of a variety of lung carcinomata. Similar observations have been made by others (Okada and Ikeda, 1970) .
Although, to date, reports on the demonstration of tumour associated antigens in human bronchogenic carcinoma are not extensive, the indication in all the evidence so far published is that some common antigens may be present in this rather heterogeneous group of neoplasms. The present study was undertaken in an attempt to extend the body of knowledge to a point where some general conclusions might be drawn. Heterologous absorbed rabbit antisera to individual tumour extracts of a variety of pathological types of tumours were tested against a panel of 50 different tumour extracts, foetal extracts and extracts of either TUMOUR ASSOCIATED ANTIGENS IN BRONCHOGENIC CARCINOMA pooled or individual normal human lung tissues. The findings are reported in this paper.
MATERIALS AND METHODS
Extraction methods.-All tissues were treated in essentially the same way. Tumours were obtained from either post mortem specimens or from surgical pneumonectomies; one tumour (C-24) was obtained as a metastatic tumour in the liver. They were prepared by excising all apparently normal tissue before grinding and extraction of the tumour. Normal lung preparations were obtained as post mortem specimens from patients dying from non-malignant disease. Foetal lungs were removed from 12-18 week saline induced aborted foetuses. Tissues were teased to separate individual cells and passed through a tissue grinder. The tissue volume was measured and 6 times the volume of 3 -5 mol/l KCl was added, bringing the final salt concentration to 3 -0 mol/l. Extractions were carried out with gentle agitation at 4°C for 18 h, after which the cell debris was removed by centrifugation at 16,000 g for 90 min. Cell extracts were dialysed exhaustively with several changes of phosphate buffered saline (PBS, 0 -15 mol/l, pH 7 -2), after which they were again centrifuged at 16,000 g for 90 min. The extracts were sterilized by Millipore filtration and stored at -20°C.
Protein concentrations of the extracts were estimated by the standard Lowry technique. Tumour extracts contained between 5 -0 and 15-0 mg/ml. Many of the normal extracts were maintained at considerably higher protein concentrations (30 -0 mg/ml) in order to minimize the possibility of regarding relatively small quantitative differences in cell components as tumour specific materials.
Anti8era.-Randomly bred albino rabbits were immunized by 8 weekly injections of tumour extract. Dose levels were at 7-5 mg of protein in 1 0 ml of 50% complete Freund's adjuvant, administered in 5 locations-4 intramuscularly in each limb and one intraperitoneally. Animals were test bled 10 days after the last injection by the ear vein and their serum tested by immunodiffusion with the homologous extract. If the antiserum, after immunoadsorption, failed to detect tumour associated material, further immunizations were carried out. Final bleeding was carried out by cardiac puncture. Serum was stored at -20TC.
Immunoabsorption.-An immunoadsorbent was prepared by binding a pool of 8 normal lung extracts to Sepharose 413 with cyanogen bromide. The technique has been described in detail previously (Watson, Smith and Levy, 1974) . The only changes in the basic technique was that the " antinormal" antibody were eluted fronm the columns with Sorensen's buffer (glvcine-HCl, pH 2 -6), and the columns were regenerated with starting buffer.
Before the eluted anti-tumour antibody was concentrated, it was further absorbed on a glutaraldehyde insolubilized preparation of normal lung extract. This immunoadsorbent was prepared according to the method of Avrameas and Ternynck (1969) with the following modification: Normal lung extracts to be treated were dialysed against 0 -1 mol/l acetate buffer pH 5-0 at 4°C overnight. Glutaraldehyde at a concentration of 25% was added slowly, with stirring, to a final concentration of 50 mg/ 100 mg protein. The mixture was stirred at room temperature for 4 h, after which it was allowed to react for 18 h at 4 TC. The mixture was diluted 1: 5 with PBS and centrifuged at 2000 g for 15 min at 4TC. The pellet was homogenized and washed again with PBS, after which it was again homogenized and washed with 0-1 mol/l glycine-HCl buffer at 2-8. The insolubilized material was washed a further 2 times with PBS, homogenized and stored in PBS at 4°C.
Absorption of the anti-tumour antiserum was carried out using a 1 : 1 volume of antiserum and insoluble normal extract. Absorption was carried out at 4"C for 18 h, after which the insoluble material was removed by centrifugation. The supernatant was concentrated by either ultrafiltration on an XM 100 A ultrafiltration membrane (Amicon) or by precipitation with 50% saturated (NH4)2SO4. The glutaraldehyde insolubilized immunoadsorbents were not re-used.
Immunodiffusion.-Immunodiffusion was carried out on glass slides using 0-85% Jonagar and a template for 6 samples around a centre well. Antiserum and extracts were added as 50 ,u samples and diffusions were developed at 4"C for 4 days in a humidified chamber. In some instances, titrations of Fig. 1 . The second type, when present, formed a band relatively close to the antiserum well and cross-reactivity with other tumour extracts was at a high frequency (see antisera for C-57 and C-41). This band is designated in the Tables as + (i). While the outer bands at no time showed identity with either normal or foetal extracts, the inner band in some instances showed partial identity with one foetal extract (F-48) . This is illustrated in Fig. 2 and 3 . Some extracts demonstrated the presence of both inner and outer bands, indicating that 2 separate antigens were responsible (Fig. 4) .
The possibility was considered that the inner band could be identified as carcinoembryonic antigen (CEA). Tests run on extracts which were either positive or negative for the presence of this reactive material showed that no correlation existed between CEA levels and the presence of the inner precipitin band. A large selection of tumour extracts as well as normal lung extracts were tested for the presence of CEA by the standard CEARoche Test Kit. Many of the tumour extracts contained appreciable levels of CEA (>100 ng/ml) whereas others contained very low levels. Because the assayed levels of CEA did not correlate in any way with those extracts showing the presence of the inner band, it was felt that it was unlikely that the antigen in this instance was CEA. would appear that bronchogenic carcinoma cells may contain at least 2 components which are antigenic in a xenogeneic species and which are either absent or present in very low concentrations in normal lung tissue. One of the components appears to be cross-reactive but not identical to a component present in the extracts of foetal lung. This component is neither CEA nor ax-1foetoportein. When antibodies to this component were present in appreciable amounts in absorbed antisera, the level of cross-reactivity between tumour extracts was found to be very extensive (see antisera C-41, C-57 and C-62 in particular). The reaction of this antibody with foetal extracts, on the other hand, was very weak and not detectable in most instances, even though the protein concentrations in the foetal extracts were generally higher than in the tumour extracts. This would imply that this constituent is not present in high concentrations in foetal lung. The nature of this component requires considerably more investigation before further conclusions can be drawn. It is interesting to note that earlier investigators (Yachi et al., 1968) made the observation that a high percentage of the bronchogenic carcinoma extracts that they were studying contained a component which shared partial identity with a foetal antigen.
The second antigenic component(s) observed in this study is impossible to evaluate at this time. Whether or not the degree of cross-reactivity observed with antisera and the tumour extract panel is reliable cannot be assessed. It is still not clear whether all the outer precipitin bands observed are identical antigens even for an individual antiserum. It is possible that a greater degree of crossreactivity may exist than was observed here since the methods used here for antigen detection are not very sensitive. This is apparent from our not infrequent observation that an antiserum would show no specific precipitation with the homologous antigen but would show significant precipitation with a heterologous tumour extract (see Fig. 1 ). The limit for detection of antigenic materials by the immunodiffusion technique used here is in the region of 2 0 ,tg/ml. It is possible that hyperimmunized rabbits could mount a considerable immune response to components in the extract present in concentrations lower than this level, and thus give rise to antisera which demonstrate tumour associated antigens in heterologous extracts (which contained higher concentrations of the antigen) but fail to do so with the homologous extract. It is also important to recognize the possibility that bacterial or viral contaminating antigens may be responsible for the formation of these bands since tumour specimens taken from the lung are invariably heavily contaminated.
The control tests included 3 individual extracts from lung tissue taken at post mortem from patients dying from nonmalignant causes, as well as a pooled extract from 8 other individuals. In no instance did these extracts demonstrate positive immunodiffusion bands with the absorbed antisera which were reported as positive in this study. It is clearly impossible to ascertain at this point whether these data indicate qualitative or quantitative differences between lung tumour tissues and normal lung tissue.
Until these antigenic components have been purified and high titre monospecific antiserum prepared to them, these uncertainties cannot be clarified. Preliminary studies indicate that such an undertaking is possible and work is currently under way which addresses itself to these issues. 
